{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:06:01Z","timestamp":1788599161523,"version":"build-2803163510"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Postorgasmic illness syndrome (POIS) is a rare, poorly understood condition that is characterized by feeling ill after orgasm. Despite its significant impact on quality of life, POIS remains poorly understood, and effective treatment options are limited without clear guidelines. Only 18% of sexual medicine experts report symptom improvement in more than 30% of the patients. Current treatments have been used to address the various presentations such as flu-like state, mood disturbances and\/or irritability, as well as congestion and inflammation. Given the lack of standardized therapeutic approaches, there is a critical need to document and evaluate various treatments tried for POIS management.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This systematic review aims to evaluate current treatment modalities for POIS and compile solutions that have been studied and tested.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A search was conducted in June 2024 of 3 of the most relevant databases (PubMed, Embase, and Scopus) of clinical studies, randomized controlled trials, and case reports analyzing treatment modalities of patients with diagnosed POIS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 58 studies found, 14 matched our inclusion criteria. Our systematic review consists of 1 cross-sectional study, 1 cohort study, and 12 case reports. Two papers included female patients, and the rest studied only male patients. Eleven papers discussed pharmacologic treatment modalities, including antihistamines, ibuprofen, NSAIDs, hormone replacement therapy, steroids, SSRIs, alpha-blockers, beta-blockers, calcium channel blockers, and triptans. Two papers mentioned immune treatment, one being the intracutaneous injection of autologous semen and the other being intralymphatic immunotherapy with the injection of allergen-specific immunotherapy. One paper mentioned surgical treatment with bilateral epididymectomy and bilateral vasoligation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The largest limitation to continued research is related to the rarity and low recognizability of POIS; however, POIS research is on the rise. Scientists across the world are collaborating to better understand the pathophysiology behind this condition and investigate treatment modalities to address the associated symptoms.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jsxmed\/qdaf112","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T12:22:22Z","timestamp":1748434942000},"page":"1236-1243","source":"Crossref","is-referenced-by-count":5,"title":["Treatments for postorgasmic illness syndrome: a systematic review"],"prefix":"10.1093","volume":"22","author":[{"given":"Sarah","family":"Ponce","sequence":"first","affiliation":[{"name":"Keck School of Medicine, University of South California , Los Angeles, CA 90089 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana","family":"Chapalamadugu","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine , Miami, FL 33101 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Levine","sequence":"additional","affiliation":[{"name":"Saint Louis University School of Medicine , Saint Louis, MO 63104 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Stokes","sequence":"additional","affiliation":[{"name":"University of North Texas Health Science Center Texas College of Osteopathic Medicine , Fort Worth, TX 76107,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Radillo","sequence":"additional","affiliation":[{"name":"Universidad Aut\u00f3noma de Guadalajara , Guadalajara 45129 ,","place":["Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Johnson","sequence":"additional","affiliation":[{"name":"Idaho College of Osteopathic Medicine , Meridian, MS 83642 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Bronson","sequence":"additional","affiliation":[{"name":"University of Massachusetts Chan Medical School , Worcester, MA 01655 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S","family":"Rubin","sequence":"additional","affiliation":[{"name":"Department of Urology, Georgetown University , Washington, DC 20007 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"3","key":"2025070100262226000_ref1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/009262302760328280","article-title":"Postorgasmic illness syndrome: two cases","volume":"28","author":"Waldinger","year":"2002","journal-title":"J Sex Marital Ther"},{"issue":"1","key":"2025070100262226000_ref2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12610-019-0093-7","article-title":"Post orgasmic illness syndrome: what do we know till now?","volume":"29","author":"Abdessater","year":"2019","journal-title":"Basic Clin Androl"},{"issue":"4","key":"2025070100262226000_ref3","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/j.1743-6109.2010.02166.x","article-title":"Postorgasmic illness syndrome (POIS) in 45 Dutch Caucasian males: clinical characteristics and evidence for an immunogenic pathogenesis (part 1)","volume":"8","author":"Waldinger","year":"2011","journal-title":"J Sex Med"},{"issue":"4","key":"2025070100262226000_ref4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/j.1743-6109.2010.02167.x","article-title":"Hyposensitization therapy with autologous semen in two Dutch caucasian males: beneficial effects in postorgasmic illness syndrome (POIS; part 2)","volume":"8","author":"Waldinger","year":"2011","journal-title":"J Sex Med"},{"issue":"3","key":"2025070100262226000_ref5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/jsm.12813","article-title":"Postorgasmic illness syndrome (POIS) in a Chinese man: no proof for IgE-mediated allergy to semen","volume":"12","author":"Jiang","year":"2015","journal-title":"J Sex Med"},{"key":"2025070100262226000_ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.10.2009.2359","article-title":"Benign coital headache relieved by partner's pregnancies with implications for future treatment","volume":"2010","author":"Dexter","year":"2010","journal-title":"BMJ Case Rep"},{"issue":"5","key":"2025070100262226000_ref7","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1111\/j.1743-6109.2010.01707.x","article-title":"CASE REPORT: postorgasm illness syndrome\u2014a spectrum of illnesses","volume":"7","author":"Ashby","year":"2010","journal-title":"J Sex Med"},{"key":"2025070100262226000_ref8","first-page":"52S","article-title":"Post orgasmic illness syndrome: is there a place for an immunologist","volume":"147","author":"Salvade","year":"2017","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"2025070100262226000_ref9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1046\/j.1526-4610.2000.00075.x","article-title":"Expert opinion: orgasmic headaches: clinical features, diagnosis, and management","volume":"40","author":"Evans","year":"2000","journal-title":"Headache"},{"issue":"5","key":"2025070100262226000_ref10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/iju5.12184","article-title":"Case of post-orgasmic illness syndrome associated with hypogonadism","volume":"3","author":"Takeshima","year":"2020","journal-title":"IJU Case Rep"},{"key":"2025070100262226000_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2022.102189","article-title":"Post orgasmic illness syndrome successfully managed with antihistamine: a case report","volume":"45","author":"Shanholtzer","year":"2022","journal-title":"Urol Case Rep"},{"issue":"6","key":"2025070100262226000_ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31083\/j.jomh1806130","article-title":"Post-orgasmic illness syndrome accompanied with testosterone deficiency: a case report","volume":"18","author":"Su","year":"2022","journal-title":"J Men's Health"},{"issue":"7","key":"2025070100262226000_ref13","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/1346-8138.16762","article-title":"Post-orgasmic illness syndrome with positive intradermal test for autologous semen","volume":"50","author":"Kawamura","year":"2023","journal-title":"J Dermatol"},{"issue":"21","key":"2025070100262226000_ref14","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1056\/NEJMra033121","article-title":"Advances in H1-antihistamines","volume":"351","author":"Simons","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"2025070100262226000_ref15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41443-020-0314-9","article-title":"Clinical experience with post-orgasmic illness syndrome (POIS) patients-characteristics and possible treatment modality","volume":"33","author":"Reisman","year":"2021","journal-title":"Int J Impot Res"},{"issue":"5","key":"2025070100262226000_ref16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jogc.2020.02.003","article-title":"Clinical conundrum: a 33-year-old with pain post-orgasm and a history of endometriosis","volume":"42","author":"Yong","year":"2020","journal-title":"J Obstet Gynaecol Can"},{"issue":"Suppl 1","key":"2025070100262226000_ref17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1046\/j.1468-1331.2002.0090s1030.x","article-title":"The medical management of spasticity","volume":"9","author":"Abbruzzese","year":"2002","journal-title":"Eur J Neurol"},{"issue":"5","key":"2025070100262226000_ref18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11916-007-0218-0","article-title":"Myofascial dysfunction associated with chronic pelvic floor pain: management strategies","volume":"11","author":"Srinivasan","year":"2007","journal-title":"Curr Pain Headache Rep"},{"issue":"21\u201322","key":"2025070100262226000_ref19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00508-005-0464-2","article-title":"Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study","volume":"117","author":"Sator-Katzenschlager","year":"2005","journal-title":"Wien Klin Wochenschr"},{"issue":"25","key":"2025070100262226000_ref20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"2025070100262226000_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2019.101078","article-title":"Successful treatment of post-orgasmic illness syndrome with human chorionic gonadotropin","volume":"29","author":"Bolanos","year":"2020","journal-title":"Urol Case Rep"},{"issue":"3","key":"2025070100262226000_ref22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.4103\/aja202170","article-title":"Novel treatment for post-orgasmic illness syndrome: a case report and literature review","volume":"24","author":"Huang","year":"2022","journal-title":"Asian J Androl"},{"issue":"1","key":"2025070100262226000_ref23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1471-0528.1970.tb03409.x","article-title":"Effect of daily small doses of Norgestrel on ovarian function","volume":"77","author":"Wright","year":"1970","journal-title":"J Obstet Gynaecol Br Commonw"},{"issue":"4","key":"2025070100262226000_ref24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1783\/147118908786000451","article-title":"Ovulation incidence with oral contraceptives: a literature review","volume":"34","author":"Milsom","year":"2008","journal-title":"J Fam Plann Reprod Health Care"},{"key":"2025070100262226000_ref25","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9781615375523","volume-title":"The American Psychiatric Association Publishing Textbook of Psychopharmacology","author":"Schatzberg","year":"2024","edition":"6th ed."},{"issue":"sup1","key":"2025070100262226000_ref26","doi-asserted-by":"publisher","first-page":"s51","DOI":"10.1185\/0300799039117016","article-title":"Naratriptan","volume":"17","author":"Massiou","year":"2001","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"2025070100262226000_ref27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1080\/0092623X.2023.2295256","article-title":"Post-orgasmic illness syndrome successfully treated with Omalizumab: a case report","volume":"50","author":"McLean-Tooke","year":"2024","journal-title":"J Sex Marital Ther"},{"issue":"9","key":"2025070100262226000_ref28","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1001\/jama.1975.03250090034016","article-title":"Corticosteroid therapy. I. Pharmacological properties and principles of corticosteroid use","volume":"232","author":"Streeten","year":"1975","journal-title":"JAMA."},{"issue":"1_suppl","key":"2025070100262226000_ref29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1177\/096120330501400102","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus."},{"issue":"4","key":"2025070100262226000_ref30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4103\/0019-5154.160490","article-title":"Omalizumab \u2013 a review","volume":"60","author":"Godse","year":"2015","journal-title":"Indian J Dermatol"},{"issue":"7","key":"2025070100262226000_ref31","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1111\/jsm.12093","article-title":"Orgasmic headache treated with nimodipine","volume":"10","author":"Lee","year":"2013","journal-title":"J Sex Med"},{"issue":"2","key":"2025070100262226000_ref32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S1042-3680(18)30812-X","article-title":"Calcium antagonists and vasospasm","volume":"1","author":"Meyer","year":"1990","journal-title":"Neurosurg Clin N Am"},{"issue":"14","key":"2025070100262226000_ref33","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1517\/14656566.2012.714368","article-title":"Silodosin\u00a0: a new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia","volume":"13","author":"Osman","year":"2012","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"2025070100262226000_ref34","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1751-7176.2011.00515.x","article-title":"\u0392-adrenergic blockers","volume":"13","author":"Frishman","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"2025070100262226000_ref35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.esxm.2017.12.004","article-title":"Intralymphatic immunotherapy with autologous semen in a Korean man with post-orgasmic illness syndrome","volume":"6","author":"Kim","year":"2018","journal-title":"Sex Med"},{"issue":"3","key":"2025070100262226000_ref36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1054\/jpai.2003.434","article-title":"Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness","volume":"4","author":"Sluka","year":"2003","journal-title":"J Pain"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/7\/1236\/63390971\/qdaf112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/22\/7\/1236\/63390971\/qdaf112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T04:26:30Z","timestamp":1751343990000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/22\/7\/1236\/8152052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,5,28]]},"published-print":{"date-parts":[[2025,6,29]]}},"URL":"https:\/\/doi.org\/10.1093\/jsxmed\/qdaf112","relation":{},"ISSN":["1743-6095","1743-6109"],"issn-type":[{"value":"1743-6095","type":"print"},{"value":"1743-6109","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,5,28]]}}}